Back to News
Market Impact: 0.2
Everest Medicines Appoints Two Veteran mRNA Cancer Vaccine Scientists to Advance Global Clinical Development
Source: PRWeb
Healthcare & BiotechManagement & GovernanceTechnology & Innovation
Everest Medicines appointed Lakshmi Srinivasan, PhD, former Executive Director and Head of Oncology Translational Medicine at Moderna, and Brandon Coder, PhD, former Research & Early Translational Lead for Cancer Vaccines at Moderna. The appointments are described as supporting continued advancement of Everest’s mRNA work; the article excerpt gives no financial or clinical milestones.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mildly positive
Sentiment Score
0.20
Ticker Sentiment
MRNA0.00
More News
- Moderna options activity surges as Nasdaq-100 inclusion and melanoma data drive call buying
- For the final 10% of cystic fibrosis, the breakthrough still hasn't come
- Why Moderna Stock Surged Today
- Moderna Climbs 5% on NASDAQ 100 Entry; Pfizer Inches Higher, BioNTech Ticks Up
- Verizon stock heads for worst day since 2002 as SpaceX U.S. network plans whack telcos
- SpaceX’s Wireless Threat Rises With Spectrum Deal